急性缺血性卒中取栓术的拟达成剂量水平及剂量降低系统的影响:一项纳入1096例患者的国际多中心回顾性研究
该国际多中心回顾性研究纳入2014年1月至2017年5月五家中心1096例接受双平面血管造影系统取栓的急性大血管闭塞性缺血性卒中患者,比较配备与未配备辐射剂量降低系统(RDS)的造影系统。RDS组520例(47%),多因素分析显示RDS显著降低剂量面积乘积(DAP)35%(91 vs 140 Gy cm2,p<0.001)和空气比释动能53%(0.46 vs 0.97 Gy,p<0.001),对比剂用量、成功再通率、并发症及临床结局无差异。作者提出75百分位阈值148 Gy cm2和0.73 Gy作为可达成水平。
要点
- RDS使DAP降低35%(91 vs 140 Gy cm2,p<0.001),空气比释动能降低53%(0.46 vs 0.97 Gy,p<0.001)。
- 作者提出的国际可达成水平为75百分位:DAP 148 Gy cm2、空气比释动能0.73 Gy。
- RDS组与无RDS组在对比剂用量、成功再通率、并发症及临床结局方面无差异。
核心结论
- 辐射剂量降低系统可将DAP降低约三分之一、空气比释动能降低约一半,且不影响取栓疗效或安全性;148 Gy cm2和0.73 Gy代表可达成水平,可能有助于优化急性缺血性卒中治疗中的辐射暴露。
研究设计与样本
- 国际多中心回顾性研究,纳入五家高容量中心2014年1月至2017年5月连续接受双平面血管造影系统取栓的患者1096例,已获机构审查委员会批准。
诊断标准与关键数值
- RDS组520例(47%)使用配备RDS的双平面血管造影系统;多因素分析示RDS显著降低DAP(91 vs 140 Gy cm2,相对效应0.74(CI 0.66; 0.83),降低35%,p<0.001)和空气比释动能(0.46 vs 0.97 Gy,相对效应0.63(CI 0.56; 0.71),降低53%,p<0.001);提出的75百分位可达成水平分别为DAP 148 Gy cm2和空气比释动能0.73 Gy。
临床应用与阅片要点
- 作者认为148 Gy cm2和0.73 Gy阈值代表可达成水平,可能有助于优化当前和未来急性缺血性卒中治疗中的辐射暴露;作者预期随着技术发展这些数值会降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: International dose reference levels are lacking for mechanical thrombectomy in acute ischemic stroke patients with large vessel occlusions. We studied whether radiation dose-reduction systems (RDS) could effectively reduce exposure and propose achievable levels.
MATERIALS AND METHODS: We retrospectively included consecutive patients treated with thrombectomy on a biplane angiography system (BP) in five international, high-volume centers between January 2014 and May 2017. Institutional Review Board approvals were obtained. Technical, procedural, and clinical characteristics were assessed. Efficacy, safety, radiation dose, and contrast load were compared between angiography systems with and without RDS. Multivariate analyses were adjusted according to Bonferroni's correction. Proposed international achievable cutoff levels were set at the 75th percentile.
RESULTS: Out of the 1096 thrombectomized patients, 520 (47%) were treated on a BP equipped with RDS. After multivariate analysis, RDS significantly reduced dose-area product (DAP) (91 vs 140 Gy cm2, relative effect 0.74 (CI 0.66; 0.83), 35% decrease, p < 0.001) and air kerma (0.46 vs 0.97 Gy, relative effect 0.63 (CI 0.56; 0.71), 53% decrease, p < 0.001) with 75th percentile levels of 148 Gy cm2 and 0.73 Gy, respectively. There was no difference in contrast load, rates of successful recanalization, complications, or clinical outcome.
CONCLUSION: Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety. The respective thresholds of 148 Gy cm2 and 0.73 Gy represent achievable levels that may serve to optimize current and future radiation exposure in the setting of acute ischemic stroke treatment. As technology evolves, we expect these values to decrease.
KEY POINTS: • Internationally validated achievable levels may help caregivers and health authorities better assess and reduce radiation exposure of both ischemic stroke patients and treating staff during thrombectomy procedures. • Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety in the setting of acute ischemic stroke due to large vessel occlusion.
引用
- Guenego A, Mosimann PJ, Pereira VM, et al. Proposed achievable levels of dose and impact of dose-reduction systems for thrombectomy in acute ischemic stroke: an international, multicentric, retrospective study in 1096 patients. Eur Radiol. 2019. PMID: 30903333. doi:10.1007/s00330-019-06062-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。